While coming back down from 2023’s dizzying high, Merck & Co. still managed to hang on to the top spot of our annual R&D budgets in pharma list. Though Merck’s 2024 R&D spending plummeted by almost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results